This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Shares of The Trade Desk rose by as much as 5% on July 7, as the Ventura-based advertising technology company unveiled its new trading platform, Solimar. The Trade Desk closed at $76.56 on July 6 and traded as high as $81.59 on July 7 before closing at $77.65, up 1.5% from the previous closing date. Read More →
Procore Technologies, a Carpinteria-based company that provides software to the construction industry, announced an expansion into the Middle East and North Africa on July 6. The effort will be undertaken in partnership with Mubadala Investment Company, a sovereign investor for the government of Abu Dhabi that owns shares in Procore. “The construction sector in the Read More →
St. John’s Pleasant Valley Hospital has changed its name to St. John’s Hospital Camarillo, the hospital’s nonprofit parent, Dignity Health, announced July 6. Dignity said the hospital is changing its name to “better identify the hospital with the community it serves.” Hospital leaders don’t expect the name change to impact hospital operations or patient care. Read More →
Oxnard Airport is getting more than $14.4 million in federal funds to replace the runway, U.S. Rep. Julia Brownley, D-Westlake Village, announced July 1. The runway will completely replaced, with new pavement and markings, but will stay the same size, at 5,900 feet. The grant is coming from the Federal Aviation Administration’s Airport Improvement Program, Read More →
Shares of Westlake Village-based Arcutis Biotherapeutics dropped by as much as 5% during the trading day July 1, after the biotech company terminated phase 2 trials for a potential treatment. Arcutis, a biotech company focused on creating dermatology treatments, has announced July that it had terminated phase 2a and 2b trials for evaluating ARQ-252, a Read More →